Nerve stimulation for pulmonary arterial hypertension (Group 1)
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a nerve-stimulation treatment (neuromodulation) for people with pulmonary arterial hypertension, a type of high blood pressure in the lungs. The goal is to see if it can improve your symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with pulmonary arterial hypertension (Group 1 PH).
- Your symptoms should be at WHO functional class II or III (mild to moderate limitation).
- You must be able to walk (not wheelchair-bound or have amputations).
- You should not have active cancer or be facing a life expectancy of less than 3 to 6 months.
- You need to speak English (Spanish-speaking patients are not eligible).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
This trial tests a procedure called pulmonary artery denervation (PADN) for people with heart failure and a certain type of high blood pressure in the lungs (pulmonary hypertension Group 2). The goal is to see if using a special device called the Gradient Denervation System can help control the high pressures and improve your symptoms.
This trial studies an implanted system (the Aria CV Pulmonary Hypertension System) to treat pulmonary arterial hypertension, a serious lung-blood vessel and heart condition. It aims to see whether the device can improve outcomes for people who are still sick despite existing PH medicines.
This study tests an investigational pill (called telaglenastat) to see if it can help people with pulmonary hypertension (high blood pressure in the lungs). Researchers want to learn if this drug improves symptoms like shortness of breath and exercise ability.
This trial tests if special breathing exercises can help people with pulmonary hypertension. You may join if your condition is stable and you haven't smoked in the last 10 years.
This study tests a new procedure called pulmonary artery denervation (PADN) to lower high blood pressure in the lungs that persists after a mitral valve repair. It aims to see if this extra treatment improves symptoms and outcomes for people with this condition.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.